- Home
- Publications
- Publication Search
- Publication Details
Title
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 13, Issue 1, Pages 36-49
Publisher
Springer Nature
Online
2016-09-16
DOI
10.1038/nrendo.2016.135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
- (2016) Joel T. Haas et al. Annual Review of Physiology
- The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- (2016) Nathalie Hennuyer et al. ATHEROSCLEROSIS
- Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
- (2016) Shun Ishibashi et al. ATHEROSCLEROSIS
- Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues
- (2016) Vanessa Pellegrinelli et al. DIABETOLOGIA
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ
- (2015) Rui Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The activation of peroxisome proliferator-activated receptor γ is regulated by Krüppel-like transcription factors 6 & 9 under steatotic conditions
- (2015) Ivonne Escalona-Nandez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PPAR-β/δ activation promotes phospholipid transfer protein expression
- (2015) Khouloud Chehaibi et al. BIOCHEMICAL PHARMACOLOGY
- PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation
- (2015) Emma Barroso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Immune Regulation of Metabolic Homeostasis in Health and Disease
- (2015) Jonathan R. Brestoff et al. CELL
- PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice
- (2015) Tamiris Lima Rachid et al. CELL BIOCHEMISTRY AND FUNCTION
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
- (2015) Chrysi Koliaki et al. Cell Metabolism
- Potent peroxisome proliferator-activated receptor- agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome
- (2015) A. V. Khera et al. EUROPEAN HEART JOURNAL
- Saroglitazar for the treatment of dyslipidemia in diabetic patients
- (2015) Shashank R Joshi EXPERT OPINION ON PHARMACOTHERAPY
- Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ
- (2015) Yan Jiang et al. FASEB JOURNAL
- Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma
- (2015) Yan Zhang et al. GENE
- Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
- (2015) James D. Lewis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice
- (2015) Tamiris Lima Rachid et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure UponPparα Deficiency
- (2015) Michal Pawlak et al. MOLECULAR ENDOCRINOLOGY
- Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity
- (2015) Elise Dalmas et al. NATURE MEDICINE
- Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
- (2015) Jimmy F. P. Berbée et al. Nature Communications
- Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity
- (2015) Rafael Mayoral et al. Molecular Metabolism
- Brown Adipose Tissue Activation Is Inversely Related to Central Obesity and Metabolic Parameters in Adult Human
- (2015) Qidi Wang et al. PLoS One
- Hypoxia and Adipocyte Physiology: Implications for Adipose Tissue Dysfunction in Obesity
- (2014) Paul Trayhurn Annual Review of Nutrition
- Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch
- (2014) Paul Cohen et al. CELL
- Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
- (2014) Raymond E. Soccio et al. Cell Metabolism
- The PPARα-FGF21 Hormone Axis Contributes to Metabolic Regulation by the Hepatic JNK Signaling Pathway
- (2014) Santiago Vernia et al. Cell Metabolism
- Regulation of Steatohepatitis and PPARγ Signaling by Distinct AP-1 Dimers
- (2014) Sebastian C. Hasenfuss et al. Cell Metabolism
- β-Aminoisobutyric Acid Induces Browning of White Fat and Hepatic β-Oxidation and Is Inversely Correlated with Cardiometabolic Risk Factors
- (2014) Lee D. Roberts et al. Cell Metabolism
- Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
- (2014) Daniel Levin et al. DIABETOLOGIA
- PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism
- (2014) Laia Salvadó et al. DIABETOLOGIA
- Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers
- (2014) Anne Loft et al. GENES & DEVELOPMENT
- Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPAR -driven enhancers
- (2014) S. E. Step et al. GENES & DEVELOPMENT
- The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
- (2014) Michal Pawlak et al. HEPATOLOGY
- Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus
- (2014) A. Michael Lincoff et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial
- (2014) R. Neil A. Black et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- PPARδ activation attenuates hepatic steatosis inLdlr−/−mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
- (2014) Lazar A. Bojic et al. JOURNAL OF LIPID RESEARCH
- An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ
- (2014) Alexander S. Banks et al. NATURE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- A dynamic CTCF chromatin binding landscape promotes DNA hydroxymethylation and transcriptional induction of adipocyte differentiation
- (2014) Julie Dubois-Chevalier et al. NUCLEIC ACIDS RESEARCH
- Physiological Functions of Peroxisome Proliferator-Activated Receptor β
- (2014) Jaap G. Neels et al. PHYSIOLOGICAL REVIEWS
- Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes
- (2014) A. R. Majithia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARγ and the global map of adipogenesis and beyond
- (2014) Martina I. Lefterova et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- MitoNEET-mediated effects on browning of white adipose tissue
- (2014) Christine M. Kusminski et al. Nature Communications
- Transcription Factor Cooperativity in Early Adipogenic Hotspots and Super-Enhancers
- (2014) Rasmus Siersbæk et al. Cell Reports
- Immune Cell Toll-like Receptor 4 Mediates the Development of Obesity- and Endotoxemia-Associated Adipose Tissue Fibrosis
- (2014) Isabelle K. Vila et al. Cell Reports
- Fenofibrate Inhibits Endothelin-1 Expression by Peroxisome Proliferator–Activated Receptor α–Dependent and Independent Mechanisms in Human Endothelial Cells
- (2013) Corine Glineur et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reprogramming of the Circadian Clock by Nutritional Challenge
- (2013) Kristin L. Eckel-Mahan et al. CELL
- EBF2 Determines and Maintains Brown Adipocyte Identity
- (2013) Sona Rajakumari et al. Cell Metabolism
- Adipose Subtype-Selective Recruitment of TLE3 or Prdm16 by PPARγ Specifies Lipid Storage versus Thermogenic Gene Programs
- (2013) Claudio J. Villanueva et al. Cell Metabolism
- Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor
- (2013) Yan Yang et al. CELLULAR SIGNALLING
- PPARγ
- (2013) Frederick W. Quelle et al. CIRCULATION RESEARCH
- PPAR and Sirt1 Mediate Erythropoietin Action in Increasing Metabolic Activity and Browning of White Adipocytes to Protect Against Obesity and Metabolic Disorders
- (2013) L. Wang et al. DIABETES
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway
- (2013) Weirong Wang et al. EXPERIMENTAL CELL RESEARCH
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damage
- (2013) Maud Lemoine et al. HEPATOLOGY RESEARCH
- PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats
- (2013) K Sodhi et al. INTERNATIONAL JOURNAL OF OBESITY
- Peroxisome Proliferator-activated Receptor γ Regulates Genes Involved in Insulin/Insulin-like Growth Factor Signaling and Lipid Metabolism during Adipogenesis through Functionally Distinct Enhancer Classes
- (2013) Frédérik Oger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism
- (2013) Zhenji Gan et al. JOURNAL OF CLINICAL INVESTIGATION
- Recruited brown adipose tissue as an antiobesity agent in humans
- (2013) Takeshi Yoneshiro et al. JOURNAL OF CLINICAL INVESTIGATION
- Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells
- (2013) Eva Morán-Salvador et al. JOURNAL OF HEPATOLOGY
- A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use
- (2013) Sihao Liu et al. NATURE
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Nuclear receptor atlas of female mouse liver parenchymal, endothelial, and Kupffer cells
- (2013) Zhaosha Li et al. PHYSIOLOGICAL GENOMICS
- Identification of a Mitochondrial Target of Thiazolidinedione Insulin Sensitizers (mTOT)—Relationship to Newly Identified Mitochondrial Pyruvate Carrier Proteins
- (2013) Jerry R. Colca et al. PLoS One
- Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
- (2013) A. S. Divakaruni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPAR
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARγ-induced PARylation promotes local DNA demethylation by production of 5-hydroxymethylcytosine
- (2013) Katsunori Fujiki et al. Nature Communications
- Adiponectin, driver or passenger on the road to insulin sensitivity?
- (2013) Risheng Ye et al. Molecular Metabolism
- Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects
- (2012) Robert S. Rosenson et al. AMERICAN HEART JOURNAL
- Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol
- (2012) Eric J. Olson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
- (2012) Li Qiang et al. CELL
- Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
- (2012) Paul A. Dutchak et al. CELL
- Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial
- (2012) O. Gealekman et al. DIABETOLOGIA
- Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
- (2012) D. E. Bonds et al. DIABETOLOGIA
- Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
- (2012) S. Colin et al. EUROPEAN HEART JOURNAL
- Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
- (2012) Mi Young Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Roles for Peroxisome Proliferator-activated Receptor γ (PPARγ) and PPARγ Coactivators 1α and 1β in Regulating Response of White and Brown Adipocytes to Hypoxia
- (2012) Elizabeth Pino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation
- (2012) Amine Toubal et al. JOURNAL OF CLINICAL INVESTIGATION
- PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
- (2012) Aina Rodríguez-Vilarrupla et al. JOURNAL OF HEPATOLOGY
- A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
- (2012) Johan W. Jonker et al. NATURE
- MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity
- (2012) Christine M Kusminski et al. NATURE MEDICINE
- Nuclear Hormone Receptors Enable Macrophages and Dendritic Cells to Sense Their Lipid Environment and Shape Their Immune Response
- (2012) Laszlo Nagy et al. PHYSIOLOGICAL REVIEWS
- Hepatic Lipid Accumulation Alters Global Histone H3 Lysine 9 and 4 Trimethylation in the Peroxisome Proliferator-Activated Receptor Alpha Network
- (2012) Hee-Jin Jun et al. PLoS One
- Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor
- (2012) W. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear receptor PPAR -regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis
- (2012) Y. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- In VitroandIn VivoCharacterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist
- (2012) B. K. He et al. PPAR Research
- GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
- (2012) Radina Kostadinova et al. Cell and Bioscience
- Adiponectin Regulation of Stellate Cell Activation via PPARγ-Dependent and -Independent Mechanisms
- (2011) Mahnoush S. Shafiei et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
- (2011) Meng Lee et al. ATHEROSCLEROSIS
- Activation of Peroxisome Proliferator-Activated Receptor- /- (PPAR- /- ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6-Stimulated Adipocytes
- (2011) L. Serrano-Marco et al. DIABETES
- Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
- (2011) B. Cariou et al. DIABETES CARE
- The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
- (2011) L. Serrano-Marco et al. DIABETOLOGIA
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
- (2011) Eva Morán-Salvador et al. FASEB JOURNAL
- Control of nuclear receptor activities in metabolism by post-translational modifications
- (2011) Wahiba Berrabah et al. FEBS LETTERS
- PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
- (2011) Mehdi Daoudi et al. GASTROENTEROLOGY
- Pharmacological Activation of Peroxisome Proliferator-activated Receptor δ Improves Insulin Resistance and Hepatic Steatosis in High Fat Diet-induced Diabetic Mice
- (2011) H.-T. Wu et al. HORMONE AND METABOLIC RESEARCH
- Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra
- (2011) Jonathan P. Whitehead INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Peroxisome Proliferator-activated Receptor α (PPARα) Induces PPARγ Coactivator 1α (PGC-1α) Gene Expression and Contributes to Thermogenic Activation of Brown Fat
- (2011) Elayne Hondares et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Peroxisome proliferator-activated receptor-α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis
- (2011) Claire Z Larter et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes
- (2011) Tsuyoshi Goto et al. JOURNAL OF LIPID RESEARCH
- PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver
- (2011) Mohamed A. Abdelmegeed et al. JOURNAL OF NUTRITION
- Brown adipose tissue activity controls triglyceride clearance
- (2011) Alexander Bartelt et al. NATURE MEDICINE
- Metabolic nuclear receptor signaling and the inflammatory acute phase response
- (2011) Nicolas Venteclef et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
- (2010) T. M. E. Davis et al. DIABETOLOGIA
- Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells
- (2010) Teresa Coll et al. ENDOCRINOLOGY
- Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
- (2010) Sihao Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
- (2010) Eric Bruckert et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Proteasomal degradation of retinoid X receptor α reprograms transcriptional activity of PPARγ in obese mice and humans
- (2010) Bruno Lefebvre et al. JOURNAL OF CLINICAL INVESTIGATION
- Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells
- (2010) Lin-Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Activation of PPARδ promotes mitochondrial energy metabolism and decreases basal insulin secretion in palmitate-treated β-cells
- (2010) Li Jiang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
- (2010) Benjamin F Voight et al. NATURE GENETICS
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twist-1 Is a PPARδ-Inducible, Negative-Feedback Regulator of PGC-1α in Brown Fat Metabolism
- (2009) Dongning Pan et al. CELL
- Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARα in high fat diet-induced obese mice
- (2009) Sunhyo Jeong et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes
- (2009) Natasa Petrovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man
- (2009) Constantinos Christodoulides et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sumoylated PPARα mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice
- (2009) Nicolas Leuenberger et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-α expression, a novel mechanism for the pathogenesis of NAFLD
- (2009) Lin Zheng et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- PPARδ is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction
- (2009) Kim Ravnskjaer et al. JOURNAL OF LIPID RESEARCH
- Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
- (2009) Carlos L. J. Vrins et al. JOURNAL OF LIPID RESEARCH
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- C/EBP and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor Agonists
- (2009) C. Vernochet et al. MOLECULAR AND CELLULAR BIOLOGY
- Cold-Activated Brown Adipose Tissue in Healthy Men
- (2009) Wouter D. van Marken Lichtenbelt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
- (2009) Linda M. Sanderson et al. PHYSIOLOGICAL GENOMICS
- Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)
- (2008) Robert Wilcox et al. AMERICAN HEART JOURNAL
- Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
- (2008) Olga Gealekman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
- (2008) John S. Millar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27
- (2008) Kimihiko Matsusue et al. Cell Metabolism
- Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin Sensitivity
- (2008) Kihwa Kang et al. Cell Metabolism
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
- (2008) C. Fernández-Miranda et al. DIGESTIVE AND LIVER DISEASE
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
- Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
- (2008) T. Khan et al. MOLECULAR AND CELLULAR BIOLOGY
- Ligand Activation of Peroxisome Proliferator–Activated Receptor β/δ (PPARβ/δ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression
- (2008) Weiwei Shan et al. TOXICOLOGICAL SCIENCES
- Fibrates and future PPARα agonists in the treatment of cardiovascular disease
- (2008) Bart Staels et al. Nature clinical practice. Cardiovascular medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More